What does Enanta Pharmaceuticals, Inc. do?
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and…
What is Enanta Pharmaceuticals, Inc.'s P/E and P/B ratio?
Enanta Pharmaceuticals, Inc. has a P/E ratio of -4.8 and a P/B ratio of 3.35.
What is Enanta Pharmaceuticals, Inc.'s debt-to-equity ratio?
Enanta Pharmaceuticals, Inc. has a debt-to-equity ratio of 1.80.
How much does Enanta Pharmaceuticals, Inc. owe compared with what it owns?
Enanta Pharmaceuticals, Inc. owes $0.66 for every $1 it owns (balance sheet Jun 2026), which is moderate.
What is Enanta Pharmaceuticals, Inc.'s Positivity rank?
Enanta Pharmaceuticals, Inc. is ranked #5,460 of 6,774 companies globally and #2,972 of 4,000 in United States on PositoAI, with a Positivity Score of 17,319.
Does Enanta Pharmaceuticals, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Enanta Pharmaceuticals, Inc..
Where can I read the latest news about Enanta Pharmaceuticals, Inc.?
Recent headlines about Enanta Pharmaceuticals, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Enanta Pharmaceuticals, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Enanta Pharmaceuticals, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.